Sutureless aortic valve replacement in high-risk patients with active infective endocarditis.

ABSTRACT:

Background

Surgical aortic valve replacement remains the gold standard of treatment in patients with active infective endocarditis. Such procedures tend to carry a significantly higher operative risk when compared to the conventional aortic valve replacement for a non-infective aortic valve disease. Sutureless aortic valve replacement (SU-AVR) has been introduced into cardiac surgery to allow for a simpler implementation of minimally invasive procedures. Although SU-AVR in several extended indications has proven to be successful, the data on the implementation of SU-AVR in patients with infective aortic valve endocarditis remain scarce. The aim of the study was to examine the feasibility of SU-AVR in high-risk patients with active infective aortic valve endocarditis.

Methods

SUBMITTER: Zubarevich A 

PROVIDER: S-EPMC9562544 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature